₹ 60.38 Cr
2.44%
S&P BSE Healthcare TRI
INF397L01LG2
5000.0
500.0
Karan Doshi
Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
---|---|---|---|
LIC MF Healthcare Fund-Regular Plan-Growth | 46.76 | 9.76 | 20.85 |
S&P BSE Healthcare TRI | 50.08 | 13.58 | 22.23 |
Equity
Debt
Others
The Scheme seeks to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors.
Company | Holdings (%) |
---|---|
Sun Pharmaceutical Industries Ltd. | 11.22 |
Cipla Ltd. | 6.5 |
JB Chemicals & Pharmaceuticals Ltd. | 6.18 |
Piramal Pharma Ltd. | 6.05 |
Divi's Laboratories Ltd. | 5.92 |
Glenmark Pharmaceuticals Ltd. | 5.62 |
Mankind Pharma Ltd. | 5.59 |
Torrent Pharmaceuticals Ltd. | 5.54 |
Dr. Reddy's Laboratories Ltd. | 4.9 |
Artemis Medicare Services Ltd. | 4.81 |
Sector | Holdings (%) |
---|---|
Healthcare | 95.04 |
Others | 2.7 |
Chemicals | 2.29 |
Scheme Name | 5Y (%) |
---|---|
LIC MF Healthcare Fund Reg Gr | 20.85 |
ICICI Pru Pharma Healthcare and Diagnostics PHD Fund Cum | 27.6 |
ABSL Pharma and Healthcare Reg Gr | 0.0 |
Tata India Pharma & Healthcare Reg Gr | 25.17 |
UTI Healthcare Reg Gr | 24.81 |
Nippon India Pharma Fund Gr Gr | 26.37 |
Mirae Asset Healthcare Reg Gr | 27.12 |
SBI HEALTHCARE Opportunities Reg Gr | 26.98 |
DSP Healthcare Reg Gr | 27.95 |
ITI Pharma and Healthcare Fund Reg Gr | 0.0 |